On Jan. 6, Barry P. Sleckman’s started his job as director of the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham.
NCI's publicly announced move to create an ad hoc working group that would review the feasibility and viability of the TMIST trial threatens to undercut this trial, said Mitchell Schnall, co-chair of ECOG-ACRIN Cancer Research Group, the group conducting the study.
In 1971, when the National Cancer Act was signed, Walter Lawrence, Jr., was one of the surgeons eager for a push forward, driven by rigorous science reviewed and funded by the federal government.
Raymond N. DuBois was named director of MUSC Hollings Cancer Center effective Aug. 17.
Stephen Nimer: Cancer patients are coming in for treatment, Florida’s COVID-19 spike notwithstanding
“Our chemotherapy and radiation therapy volumes have been very robust. Probably because of the NCI designation, we are seeing significantly more patients than last year,” Stephen D. Nimer, director of Sylvester Comprehensive Cancer Center, said to The Cancer Letter. “Compared to last year, we seem to be up about 15%. We’ve been growing by about 8% to 9% for quite some years. This year is even more.”
Jason M. Hafron, director of research at the Michigan Institute of Urology, was taken aback by the results of a study he was conducting: the vast majority of patients with prostate cancer who need regular injections to suppress their testosterone levels didn't get treated on time.
In early March, when Giuseppe Curigliano, an oncologist in Milan, first spoke with The Cancer Letter about COVID-19, the situation in Italy was “like being in a war zone.”
As cases of COVID-19 surge in Florida, Lucio Gordan, managing physician and president of Florida Cancer Specialists and Research Institute, is working to increase the role of telehealth.
Last time Ruben Mesa spoke with The Cancer Letter, COVID-19 was under control in San Antonio and the environs—or so it seemed.
By making lung cancer screening available to a larger population, the new guideline from the U.S. Preventive Services Task Force could save an additional 120 lives per 100,000 Americans, said Michael J. Barry, a member of the Task Force, and a professor of medicine at Harvard Medical School.
